Segall Bryant & Hamll Intl Eq Inst holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
Segall Bryant & Hamill International Equity Fund - Institutional Class CIEQX
- NAV / 1-Day Return 15.60 / −0.38 %
- Total Assets 14.4M
-
Adj. Expense Ratio
0.840%
- Expense Ratio 0.860%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Foreign Large Value
- Investment Style Large Value
- Min. Initial Investment 250,000
- Status Open
- TTM Yield 1.36%
- Turnover 107%
USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:43 AM GMT+0
Morningstar’s Analysis CIEQX
Will CIEQX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 15.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Roche Holding AG Ordinary Shares new | 2.35 | 345,064 | Healthcare |
ASML Holding NV | 1.85 | 271,689 | Technology |
Novartis AG Registered Shares | 1.57 | 230,010 | Healthcare |
BNP Paribas Act. Cat.A | 1.55 | 226,833 | Financial Services |
Banco Bilbao Vizcaya Argentaria SA | 1.48 | 216,832 | Financial Services |
GSK PLC | 1.45 | 212,500 | Healthcare |
Kioxia Holdings Corp Ordinary Shares | 1.40 | 205,894 | Technology |
UniCredit SpA | 1.34 | 196,298 | Financial Services |
NatWest Group PLC | 1.31 | 192,799 | Financial Services |
Infineon Technologies AG | 1.28 | 187,386 | Technology |